IL68250A - Plurilamellar vesicles and their preparation - Google Patents

Plurilamellar vesicles and their preparation

Info

Publication number
IL68250A
IL68250A IL68250A IL6825083A IL68250A IL 68250 A IL68250 A IL 68250A IL 68250 A IL68250 A IL 68250A IL 6825083 A IL6825083 A IL 6825083A IL 68250 A IL68250 A IL 68250A
Authority
IL
Israel
Prior art keywords
preparation
plurilamellar vesicles
plurilamellar
vesicles
Prior art date
Application number
IL68250A
Other languages
English (en)
Other versions
IL68250A0 (en
Original Assignee
Liposome Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/476,496 external-priority patent/US4522803A/en
Application filed by Liposome Corp filed Critical Liposome Corp
Publication of IL68250A0 publication Critical patent/IL68250A0/xx
Publication of IL68250A publication Critical patent/IL68250A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL68250A 1982-03-29 1983-03-28 Plurilamellar vesicles and their preparation IL68250A (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US36299482A 1982-03-29 1982-03-29
US36299582A 1982-03-29 1982-03-29
US41146682A 1982-08-25 1982-08-25
US44724782A 1982-12-06 1982-12-06
US46390083A 1983-02-04 1983-02-04
US06/476,496 US4522803A (en) 1983-02-04 1983-03-24 Stable plurilamellar vesicles, their preparation and use

Publications (2)

Publication Number Publication Date
IL68250A0 IL68250A0 (en) 1983-06-15
IL68250A true IL68250A (en) 1990-02-09

Family

ID=27559847

Family Applications (1)

Application Number Title Priority Date Filing Date
IL68250A IL68250A (en) 1982-03-29 1983-03-28 Plurilamellar vesicles and their preparation

Country Status (14)

Country Link
EP (1) EP0092453B1 (da)
AU (1) AU564876B2 (da)
DD (1) DD210217A5 (da)
DE (1) DE3373273D1 (da)
DK (1) DK163105C (da)
FI (1) FI83161C (da)
GR (1) GR78163B (da)
HK (1) HK96190A (da)
IE (1) IE54706B1 (da)
IL (1) IL68250A (da)
NZ (1) NZ203746A (da)
PT (1) PT76476B (da)
SG (1) SG13489G (da)
WO (1) WO1983003383A1 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5030453A (en) * 1983-03-24 1991-07-09 The Liposome Company, Inc. Stable plurilamellar vesicles
DE3336583A1 (de) * 1983-09-26 1985-04-25 Udo Dr. 8400 Regensburg Ehrenfeld Erzeugnis zur diagnose und therapie von malignen tumoren
DE3483949D1 (de) * 1983-09-26 1991-02-21 Udo Dr Med Ehrenfeld Mittel und erzeugnis fuer die diagnose und therapie von tumoren sowie zur behandlung von schwaechen der zelligen und humoralen immunabwehr.
JPH0753661B2 (ja) * 1984-03-08 1995-06-07 フアレス フアーマスーチカル リサーチ エヌブイ プロ―リポソーム組成物及びリポソームの水性分散物を作る方法
FR2562421B1 (fr) * 1984-04-09 1989-02-17 Sandoz Sa Perfectionnements a la therapie par l'interleukine
AU591466B2 (en) * 1984-10-22 1989-12-07 Vestar, Inc. Method of delivering micellular particles encapsulating imaging and chemotherapeutic agents to tumors in a body
EP0179660A3 (en) * 1984-10-26 1987-08-12 The Liposome Company, Inc. Multilayered vesicles prepared by reverse-phase evaporation
BE902199A (fr) * 1984-10-29 1985-07-31 Vira Tek Inc Procede de traitement medical de maladies virales utilisant le 1-beta-d-ribofurannosyl-1, 2,4-triazole-3-carboxamide.
US5409704A (en) * 1985-06-26 1995-04-25 The Liposome Company, Inc. Liposomes comprising aminoglycoside phosphates and methods of production and use
EP0231261B1 (en) * 1985-07-05 1994-04-06 The Liposome Company, Inc. Multilamellar liposomes having improved trapping efficiencies
IL79114A (en) * 1985-08-07 1990-09-17 Allergan Pharma Method and composition for making liposomes
US4983397A (en) * 1985-08-19 1991-01-08 Board Of Regents, University Of Texas System Pharmaceutical compositions consisting of acylated phospholipids
DE3787826T2 (de) * 1986-03-26 1994-04-14 Syntex Inc Einzelnes flüssiges Reagens für Tests.
US5068198A (en) * 1986-03-26 1991-11-26 Syntex (U.S.A.) Inc. Liquid single reagent for assays involving confining gels
JPH0751496B2 (ja) * 1986-04-02 1995-06-05 武田薬品工業株式会社 リポソ−ムの製造法
CA1320130C (en) * 1986-06-12 1993-07-13 Alan L. Weiner Methods and compositions using liposome-encapsulated non-steroidal anti-inflammatory drugs
PT85537B (pt) * 1986-08-18 1990-06-29 Univ Texas Processo para a preparacao de um sistema de administracao farmaceutica contendo peptidos apresentando quimiotaxia
MX9203808A (es) * 1987-03-05 1992-07-01 Liposome Co Inc Formulaciones de alto contenido de medicamento: lipido, de agentes liposomicos-antineoplasticos.
US4914088A (en) * 1987-04-02 1990-04-03 Thomas Glonek Dry eye treatment solution and method
FR2648462B1 (fr) * 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
MXPA03004095A (es) 2000-11-09 2004-09-10 Neopharm Inc Complejos de sn-38 con lipidos y sus metodos de uso.
WO2003030864A1 (en) 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
DE102008005673A1 (de) * 2008-01-23 2009-08-20 Universität Augsburg Bläschen, sowie Verfahren zur Herstellung und Manipulation von Bläschen
WO2016123365A1 (en) 2015-01-30 2016-08-04 The Regents Of The University Of Michigan Liposomal particles comprising biological molecules and uses thereof
AU2016238290B9 (en) 2015-03-25 2019-06-13 The Regents Of The University Of Michigan Compositions and methods for delivery of biomacromolecule agents
WO2017127503A2 (en) * 2016-01-19 2017-07-27 The Regents Of The University Of Michigan Vesicle-encapsulated socs
WO2017223085A2 (en) 2016-06-20 2017-12-28 The Regents Of The University Of Michigan Compositions and methods for delivery of biomacromolecule agents
WO2020123362A1 (en) 2018-12-10 2020-06-18 EternaTear, Inc. Ophthalmic formulations providing durable ocular lubrication

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115544A (en) * 1976-08-18 1978-09-19 Alza Corporation Ocular system made of bioerodible esters having linear ether
CH624011A5 (da) * 1977-08-05 1981-07-15 Battelle Memorial Institute
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles

Also Published As

Publication number Publication date
DK163105B (da) 1992-01-20
AU564876B2 (en) 1987-08-27
DK544883A (da) 1983-11-28
DK544883D0 (da) 1983-11-28
PT76476B (en) 1985-12-10
EP0092453A2 (en) 1983-10-26
EP0092453B1 (en) 1987-09-02
IL68250A0 (en) 1983-06-15
AU1519683A (en) 1983-10-24
DE3373273D1 (de) 1987-10-08
DK163105C (da) 1992-06-15
DD210217A5 (de) 1984-06-06
EP0092453A3 (en) 1983-12-07
WO1983003383A1 (en) 1983-10-13
GR78163B (da) 1984-09-26
PT76476A (en) 1983-04-01
FI834364A7 (fi) 1983-11-29
FI83161C (fi) 1991-06-10
SG13489G (en) 1989-07-07
FI83161B (fi) 1991-02-28
IE54706B1 (en) 1990-01-17
FI834364A0 (fi) 1983-11-29
IE830690L (en) 1983-09-29
HK96190A (en) 1990-11-30
NZ203746A (en) 1987-03-06

Similar Documents

Publication Publication Date Title
IL68250A (en) Plurilamellar vesicles and their preparation
IL68880A (en) Triazole-ethanol derivatives and their preparation
JPS57118794A (en) Imunosome and preparation thereof
SG4890G (en) 1-pyrimidinyloxy-3-hetarylalkylamino-2-propanols preparation and uses
IL71658A (en) 17-sulfonylmethylene-steroids and their preparation
GB8300723D0 (en) Preparation unit
DE3367089D1 (en) 3-phenoxy-1-azetidinecarboxamides and their use and preparation
ZA842202B (en) Phenylaminobenzenealkanols and preparation
EP0106653A3 (en) Hydroxyarylaldehyde preparation
ZA832045B (en) Iron-selenium preparation
MW1681A1 (en) 2-nitroimidazoles and preparation thereof
DE3479494D1 (en) Prostacyclines and process for their preparation
IL73876A (en) 7-acylamino-mitosanes and their preparation
IL62848A0 (en) Carbapenams and carbapen-2-ems and their preparation
GB2117757B (en) Alkylspectinomycins and their preparation
DE3370796D1 (en) Alpha-iminodiacetonitriles and methods for their preparation
DE3362618D1 (en) Phenols and their preparation
GB8428144D0 (en) Hydrophilic-film-forming preparation
GB2126230B (en) Substituted 1-pyridyloxy-3-indolylalkylamino-2-propanols preparation and use thereof
GB2129001B (en) Epoxycarbacyclin derivatives their preparation and use
DE3374560D1 (en) Cyanoalkylpiperazines and methods for their preparation and use
GB2080307B (en) 6-fluorosteroids and their preparation
DE3472250D1 (en) Novel halonitriles and their preparation
GB2141121B (en) 1-phenoxy-3-hydroxyindolyl-alkylamino-3-propanols and preparation
ZA832197B (en) Stable plurilamellar vesicles

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
EXP Patent expired